Avian Influenza Vaccines Market Size, Growth Strategies 2022-28
The global avian influenza vaccine market size was valued at USD 145.7 million in 2022 and is poised to grow at a significant CAGR of 4.3% during the forecast period 2023 to 2029. An increase in the prevalence of bird flu, rising demand for poultry meat consumption, and an increase in the number of government and private sector initiatives to improve the animal healthcare industry are some of the factors that will likely boost the growth of the avian influenza vaccines market during the forecasting period. Furthermore, the players are focusing on acquisition to maintain the growth in the market.
View Full Report: https://precisionbusinessinsights.com/market-reports/avian-influenza-vaccines-market/
The global avian influenza vaccine market segmentation:
1) Strain Type: Type H9, Type H7, Type H5, Others
2) Vaccine Type: Live Recombinant Vaccines, Inactivated Vaccines, Combination Vaccines 3) By Application: Duck & Goose, Chicken, Others
H5 Strain Segment is Dominate the Avian Influenza Vaccine Market:
Based on strain type, the global avian influenza vaccine market is segmented into type H9, type H7, type H5, and Others. H5 is the most common virus strain segment and holds most of the market share in the global influenza vaccine market. The outburst was caused by a strain of avian influenza virus called H5N1, which affected masses of chickens as well as other birds. Moreover, market players are focus one the development of advanced vaccines for H5 strain to meet the market needs.
North America Leads Avian Influenza Vaccine Market:
North America held the largest growth rate in the global avian influenza market and the market is anticipated to grow at a significant growth rate over the forecast years due to burgeoning meat and poultry industries, rising animal health spending, and the existence of a high number of veterinary institutions in the region. Furthermore, increasing government funding for raising knowledge about avian influenza viruses and enhancing vaccination efficiency is favorable impacting the market growth.
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=37365
The avian influenza vaccine market key players are Boehringer Ingelheim International GmbH (Germany), Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China), Ceva (US), Yebio Bioengineering Co., Ltd (China), Zoetis (US), FATRO S.P.A. (Italy), CAVAC (South Korea), Tianjin Ringpu Bio-Technology Co., Ltd (China), PT Japfa Comfeed Indonesia Tbk (Indonesia), Chengdu Tech-bank Biological Products Co., Ltd (China), Merck Animal Health (US), Medion (Indonesia), Avimex Animal Health (Mexico).
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian